My watch list  

3 Current news of jennewein-biotechnologie

matching the following criteria

image description
Interim status of the clinical study "Growth and Tolerance" by Jennewein Biotechnologie


Jennewein Biotechnologie GmbH, the leading manufacturer of human milk oligosaccharides, initiated its first clinical study in July 2018. The so-called "Growth and Tolerance" study will show that the supplementation of infant food with human milk oligosaccharides (HMOs) is very suitable for ...


image description
Cooperation in the field of human milk oligosaccharide research


Jennewein Biotechnologie GmbH, the global leader in the research and manufacture of human milk oligosaccharides (HMO),and Inner Mongolia Yili Industrial Group (Yili Group), China’s leading dairy company, announce today the signing of a Memorandum of Understanding on infant microbiome and human ...


image description
Jennewein Biotechnologie develops new fermentation technology for human milk oligosaccharides and expands its product portfolio


Jennewein Biotechnologie GmbH announces the introduction of a total biosynthesis approach for the production of human milk oligosaccharides (HMOs). Currently the production of HMOs by fermentation requires lactose as a starting material. Lactose is a costly dairy by-product and is difficult to ...


Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE